Eunju Seong1, Ryan Insolera2, Marija Dulovic3, Erik-Jan Kamsteeg4, Joanne Trinh3, Norbert Brüggemann5, Erin Sandford1, Sheng Li1, Ayse Bilge Ozel6, Jun Z Li6,7, Tamison Jewett8, Anneke J A Kievit9, Alexander Münchau3, Vikram Shakkottai10, Christine Klein3, Catherine A Collins2, Katja Lohmann3, Bart P van de Warrenburg11, Margit Burmeister1,6,7,12. 1. Molecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, MI. 2. Department of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor, MI. 3. Institute of Neurogenetics, University of Lübeck, Lübeck, Germany. 4. Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands. 5. Department of Neurology, University of Lübeck, Lübeck, Germany. 6. Department of Human Genetics, University of Michigan, Ann Arbor, MI. 7. Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI. 8. Department of Pediatrics, Section on Medical Genetics, Wake Forest School of Medicine, Winston-Salem, NC. 9. Department of Clinical Genetics, Erasmus MC, Rotterdam, the Netherlands. 10. Departments of Neurology and Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI. 11. Department of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Centre, Nijmegen, the Netherlands. 12. Department of Psychiatry, University of Michigan, Ann Arbor, MI.
Abstract
OBJECTIVE: To identify novel causes of recessive ataxias, including spinocerebellar ataxia with saccadic intrusions, spastic ataxias, and spastic paraplegia. METHODS: In an international collaboration, we independently performed exome sequencing in 7 families with recessive ataxia and/or spastic paraplegia. To evaluate the role of VPS13D mutations, we evaluated a Drosophila knockout model and investigated mitochondrial function in patient-derived fibroblast cultures. RESULTS: Exome sequencing identified compound heterozygous mutations in VPS13D on chromosome 1p36 in all 7 families. This included a large family with 5 affected siblings with spinocerebellar ataxia with saccadic intrusions (SCASI), or spinocerebellar ataxia, recessive, type 4 (SCAR4). Linkage to chromosome 1p36 was found in this family with a logarithm of odds score of 3.1. The phenotypic spectrum in our 12 patients was broad. Although most presented with ataxia, additional or predominant spasticity was present in 5 patients. Disease onset ranged from infancy to 39 years, and symptoms were slowly progressive and included loss of independent ambulation in 5. All but 2 patients carried a loss-of-function (nonsense or splice site) mutation on one and a missense mutation on the other allele. Knockdown or removal of Vps13D in Drosophila neurons led to changes in mitochondrial morphology and impairment in mitochondrial distribution along axons. Patient fibroblasts showed altered morphology and functionality including reduced energy production. INTERPRETATION: Our study demonstrates that compound heterozygous mutations in VPS13D cause movement disorders along the ataxia-spasticity spectrum, making VPS13D the fourth VPS13 paralog involved in neurological disorders. Ann Neurol 2018.
OBJECTIVE: To identify novel causes of recessive ataxias, including spinocerebellar ataxia with saccadic intrusions, spastic ataxias, and spastic paraplegia. METHODS: In an international collaboration, we independently performed exome sequencing in 7 families with recessive ataxia and/or spastic paraplegia. To evaluate the role of VPS13D mutations, we evaluated a Drosophila knockout model and investigated mitochondrial function in patient-derived fibroblast cultures. RESULTS: Exome sequencing identified compound heterozygous mutations in VPS13D on chromosome 1p36 in all 7 families. This included a large family with 5 affected siblings with spinocerebellar ataxia with saccadic intrusions (SCASI), or spinocerebellar ataxia, recessive, type 4 (SCAR4). Linkage to chromosome 1p36 was found in this family with a logarithm of odds score of 3.1. The phenotypic spectrum in our 12 patients was broad. Although most presented with ataxia, additional or predominant spasticity was present in 5 patients. Disease onset ranged from infancy to 39 years, and symptoms were slowly progressive and included loss of independent ambulation in 5. All but 2 patients carried a loss-of-function (nonsense or splice site) mutation on one and a missense mutation on the other allele. Knockdown or removal of Vps13D in Drosophila neurons led to changes in mitochondrial morphology and impairment in mitochondrial distribution along axons. Patient fibroblasts showed altered morphology and functionality including reduced energy production. INTERPRETATION: Our study demonstrates that compound heterozygous mutations in VPS13D cause movement disorders along the ataxia-spasticity spectrum, making VPS13D the fourth VPS13 paralog involved in neurological disorders. Ann Neurol 2018.
Authors: Brent L Fogel; Hane Lee; Joshua L Deignan; Samuel P Strom; Sibel Kantarci; Xizhe Wang; Fabiola Quintero-Rivera; Eric Vilain; Wayne W Grody; Susan Perlman; Daniel H Geschwind; Stanley F Nelson Journal: JAMA Neurol Date: 2014-10 Impact factor: 18.302
Authors: Susanne T de Bot; Michel A A P Willemsen; Sascha Vermeer; Hubertus P H Kremer; Bart P C van de Warrenburg Journal: Neurology Date: 2012-10-02 Impact factor: 9.910
Authors: B Schormair; D Kemlink; B Mollenhauer; O Fiala; G Machetanz; J Roth; R Berutti; T M Strom; B Haslinger; C Trenkwalder; D Zahorakova; P Martasek; E Ruzicka; J Winkelmann Journal: Clin Genet Date: 2018-01-24 Impact factor: 4.438
Authors: Juha Kolehmainen; Robert Wilkinson; Anna-Elina Lehesjoki; Kate Chandler; Satu Kivitie-Kallio; Jill Clayton-Smith; Ann-Liz Träskelin; Laura Waris; Anne Saarinen; Jabbar Khan; Varda Gross-Tsur; Elias I Traboulsi; Mette Warburg; Jean-Pierre Fryns; Reijo Norio; Graeme C M Black; Forbes D C Manson Journal: Am J Hum Genet Date: 2004-05-12 Impact factor: 11.025
Authors: Jennifer E Posey; Tamar Harel; Pengfei Liu; Jill A Rosenfeld; Regis A James; Zeynep H Coban Akdemir; Magdalena Walkiewicz; Weimin Bi; Rui Xiao; Yan Ding; Fan Xia; Arthur L Beaudet; Donna M Muzny; Richard A Gibbs; Eric Boerwinkle; Christine M Eng; V Reid Sutton; Chad A Shaw; Sharon E Plon; Yaping Yang; James R Lupski Journal: N Engl J Med Date: 2016-12-07 Impact factor: 91.245
Authors: Anne Grünewald; Lisa Voges; Aleksandar Rakovic; Meike Kasten; Himesha Vandebona; Claudia Hemmelmann; Katja Lohmann; Slobodanka Orolicki; Alfredo Ramirez; Anthony H V Schapira; Peter P Pramstaller; Carolyn M Sue; Christine Klein Journal: PLoS One Date: 2010-09-27 Impact factor: 3.240
Authors: Suzanne Lesage; Valérie Drouet; Elisa Majounie; Vincent Deramecourt; Maxime Jacoupy; Aude Nicolas; Florence Cormier-Dequaire; Sidi Mohamed Hassoun; Claire Pujol; Sorana Ciura; Zoi Erpapazoglou; Tatiana Usenko; Claude-Alain Maurage; Mourad Sahbatou; Stefan Liebau; Jinhui Ding; Basar Bilgic; Murat Emre; Nihan Erginel-Unaltuna; Gamze Guven; François Tison; Christine Tranchant; Marie Vidailhet; Jean-Christophe Corvol; Paul Krack; Anne-Louise Leutenegger; Michael A Nalls; Dena G Hernandez; Peter Heutink; J Raphael Gibbs; John Hardy; Nicholas W Wood; Thomas Gasser; Alexandra Durr; Jean-François Deleuze; Meriem Tazir; Alain Destée; Ebba Lohmann; Edor Kabashi; Andrew Singleton; Olga Corti; Alexis Brice Journal: Am J Hum Genet Date: 2016-03-03 Impact factor: 11.025
Authors: Wondwossen M Yeshaw; Marianne van der Zwaag; Francesco Pinto; Liza L Lahaye; Anita Ie Faber; Rubén Gómez-Sánchez; Amalia M Dolga; Conor Poland; Anthony P Monaco; Sven Cd van IJzendoorn; Nicola A Grzeschik; Antonio Velayos-Baeza; Ody Cm Sibon Journal: Elife Date: 2019-02-11 Impact factor: 8.140
Authors: John J Chen; Diane L Nathaniel; Preethi Raghavan; Maxine Nelson; Ruilin Tian; Eric Tse; Jason Y Hong; Stephanie K See; Sue-Ann Mok; Marco Y Hein; Daniel R Southworth; Lea T Grinberg; Jason E Gestwicki; Manuel D Leonetti; Martin Kampmann Journal: J Biol Chem Date: 2019-10-02 Impact factor: 5.157
Authors: Adam W Hansen; Mullai Murugan; He Li; Michael M Khayat; Liwen Wang; Jill Rosenfeld; B Kim Andrews; Shalini N Jhangiani; Zeynep H Coban Akdemir; Fritz J Sedlazeck; Allison E Ashley-Koch; Pengfei Liu; Donna M Muzny; Erica E Davis; Nicholas Katsanis; Aniko Sabo; Jennifer E Posey; Yaping Yang; Michael F Wangler; Christine M Eng; V Reid Sutton; James R Lupski; Eric Boerwinkle; Richard A Gibbs Journal: Am J Hum Genet Date: 2019-10-24 Impact factor: 11.025